![Frontiers | Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type Frontiers | Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type](https://www.frontiersin.org/files/MyHome%20Article%20Library/1082062/1082062_Thumb_400.jpg)
Frontiers | Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type
![Emerging nanomedical strategies for direct targeting of pediatric and adult diffuse gliomas | British Journal of Cancer Emerging nanomedical strategies for direct targeting of pediatric and adult diffuse gliomas | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-01884-6/MediaObjects/41416_2022_1884_Figa_HTML.png)
Emerging nanomedical strategies for direct targeting of pediatric and adult diffuse gliomas | British Journal of Cancer
![Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma | Journal of Neuroinflammation | Full Text Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma | Journal of Neuroinflammation | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12974-022-02630-8/MediaObjects/12974_2022_2630_Fig3_HTML.png)
Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma | Journal of Neuroinflammation | Full Text
![Successful treatment of an adult patient with diffuse midline glioma employing olaparib combined with bevacizumab | SpringerLink Successful treatment of an adult patient with diffuse midline glioma employing olaparib combined with bevacizumab | SpringerLink](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10637-021-01116-3/MediaObjects/10637_2021_1116_Fig1_HTML.png)
Successful treatment of an adult patient with diffuse midline glioma employing olaparib combined with bevacizumab | SpringerLink
![Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma | Journal of Neuroinflammation | Full Text Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma | Journal of Neuroinflammation | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12974-022-02630-8/MediaObjects/12974_2022_2630_Fig1_HTML.png)
Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma | Journal of Neuroinflammation | Full Text
![Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma - eBioMedicine Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma - eBioMedicine](https://www.thelancet.com/cms/attachment/6bd5e7ef-d83b-4df2-8430-8bd492dba30e/gr2_lrg.jpg)
Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma - eBioMedicine
![Radiosensitisation by olaparib through focused ultrasound delivery in a diffuse midline glioma model - ScienceDirect Radiosensitisation by olaparib through focused ultrasound delivery in a diffuse midline glioma model - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168365923002493-ga1.jpg)
Radiosensitisation by olaparib through focused ultrasound delivery in a diffuse midline glioma model - ScienceDirect
![Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation | American Journal of Neuroradiology Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation | American Journal of Neuroradiology](https://www.ajnr.org/content/ajnr/38/4/795/F5.large.jpg)
Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation | American Journal of Neuroradiology
![Frontiers | Treatment Strategies in Diffuse Midline Gliomas With the H3K27M Mutation: The Role of Convection-Enhanced Delivery in Overcoming Anatomic Challenges Frontiers | Treatment Strategies in Diffuse Midline Gliomas With the H3K27M Mutation: The Role of Convection-Enhanced Delivery in Overcoming Anatomic Challenges](https://www.frontiersin.org/files/Articles/426109/fonc-09-00031-HTML/image_m/fonc-09-00031-g002.jpg)
Frontiers | Treatment Strategies in Diffuse Midline Gliomas With the H3K27M Mutation: The Role of Convection-Enhanced Delivery in Overcoming Anatomic Challenges
![PDF] Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation | Semantic Scholar PDF] Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/62261efb0465d319e490a6f411df2677c3445380/4-Figure2-1.png)
PDF] Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation | Semantic Scholar
![Preliminary findings of German-sourced ONC201 treatment in H3K27 altered pediatric pontine diffuse midline gliomas | Journal of Neuro-Oncology Preliminary findings of German-sourced ONC201 treatment in H3K27 altered pediatric pontine diffuse midline gliomas | Journal of Neuro-Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11060-023-04347-x/MediaObjects/11060_2023_4347_Figa_HTML.png)
Preliminary findings of German-sourced ONC201 treatment in H3K27 altered pediatric pontine diffuse midline gliomas | Journal of Neuro-Oncology
![Diffuse midline glioma treated with epigenetic agent-based immunotherapy | Signal Transduction and Targeted Therapy Diffuse midline glioma treated with epigenetic agent-based immunotherapy | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-01274-7/MediaObjects/41392_2022_1274_Fig1_HTML.png)